Orexin 2 receptor as a potential target for immunotoxin and antibody-drug conjugate cancer therapy

Author：                

Publisher： Spandidos Publications

ISSN： 1792-1074

Source： Oncology Letters, Vol.3, Iss.3, 2012-01, pp. : 525-529

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Frizzled2: A potential novel target for molecular pancreatic cancer therapy

By            

Oncology Letters, Vol. 7, Iss. 1, 2014-01 ,pp. : 74-78

Spandidos Publications

Access to resources Recommend Favorite

Treatment parameters modulating regression of human melanoma xenografts by an antibody–drug conjugate (CR011-vcMMAE) targeting GPNMB

By Pollack Vincent   Alvarez Enrique   Tse Kam   Torgov Michael   Xie Sam   Shenoy Suresh   MacDougall John   Arrol Sharon   Zhong Haihong   Gerwien Robert   Hahne William   Senter Peter   Jeffers Michael   Lichenstein Henri   LaRochelle William  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 3, 2007-08 ,pp. : 423-435

Springer Publishing Company

Access to resources Recommend Favorite

The HOX Gene Network as a Potential Target for Cancer Therapy

By  

Current Cancer Therapy Reviews, Vol. 3, Iss. 1, 2007-02 ,pp. : 17-24

Bentham Science Publishers

Access to resources Recommend Favorite

CYP24A1 as a Potential Target for Cancer Therapy

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 1, 2014-01 ,pp. : 97-108

Bentham Science Publishers

Access to resources Recommend Favorite

CD44v6: a target for antibody-based cancer therapy

By Heider Karl-Heinz   Kuthan Hartmut   Stehle Gerd   Munzert Gerd  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 7, 2004-07 ,pp. : 567-579

Springer Publishing Company

Access to resources Recommend Favorite